Канада - англійська - Health Canada

mylan pharmaceuticals ulc - verapamil hydrochloride - tablet (extended-release) - 180mg - verapamil hydrochloride 180mg - miscellaneous calcium-channel blocking agents

Канада - англійська - Health Canada

mylan pharmaceuticals ulc - verapamil hydrochloride - tablet (extended-release) - 240mg - verapamil hydrochloride 240mg - miscellaneous calcium-channel blocking agents

США - англійська - NLM (National Library of Medicine)

remedyrepack inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacolo

США - англійська - NLM (National Library of Medicine)

remedyrepack inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride tablets are indicated for the treatment of the following: angina 1. angina at rest including: – vasospastic (prinzmetal’s variant) angina – unstable (crescendo, pre-infarction) angina 2. chronic stable angina (classic effort-associated angina) arrhythmias 1. in association with digitalis for the control of ventricular rate at rest and during stress in patients with chronic atrial flutter and/or atrial fibrillation (see warnings; accessory bypass tract ) 2. prophylaxis of repetitive paroxysmal supraventricular tachycardia essential hypertension: verapamil is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. control of high blood pressure should be part of comprehensive cardiov

США - англійська - NLM (National Library of Medicine)

remedyrepack inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride tablets are indicated for the treatment of the following: angina 1. angina at rest including: – vasospastic (prinzmetal’s variant) angina – unstable (crescendo, pre-infarction) angina 2. chronic stable angina (classic effort-associated angina) arrhythmias 1. in association with digitalis for the control of ventricular rate at rest and during stress in patients with chronic atrial flutter and/or atrial fibrillation (see warnings; accessory bypass tract ) 2. prophylaxis of repetitive paroxysmal supraventricular tachycardia essential hypertension: verapamil is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. control of high blood pressure should be part of comprehensive cardiov

США - англійська - NLM (National Library of Medicine)

cardinal health - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride injection, usp is indicated for the following: • rapid conversion to sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (wolff-parkinson-white [w-p-w] and lown-ganong- levine [l-g-l] syndromes). when clinically advisable, appropriate vagal maneuvers (e.g., valsalva maneuver) should be attempted prior to verapamil hydrochloride administration. • temporary control of rapid ventricular rate in atrial flutter or atrial fibrillation except when the atrial flutter and/or atrial fibrillation are associated with accessory bypass tracts (wolff-parkinson-white (w-p-w) and lown-ganong-levine (l-g-l) syndromes). in controlled studies in the united states, about 60% of patients with supraventricular tachycardia converted to normal sinus rhythm within 10 minutes after intravenous verapamil hydrochloride. uncontrolled studies reported in the world literature describe a conversion rate of about 80%. about 70% of patients with atrial flutte

США - англійська - NLM (National Library of Medicine)

northwind pharmaceuticals - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 240 mg in 30

Канада - англійська - Health Canada

mylan pharmaceuticals ulc - verapamil hydrochloride - tablet (extended-release) - 120mg - verapamil hydrochloride 120mg - miscellaneous calcium-channel blocking agents

Канада - англійська - Health Canada

mylan pharmaceuticals ulc - verapamil hydrochloride - tablet - 80mg - verapamil hydrochloride 80mg - miscellaneous calcium-channel blocking agents

Канада - англійська - Health Canada

mylan pharmaceuticals ulc - verapamil hydrochloride - tablet - 120mg - verapamil hydrochloride 120mg - miscellaneous calcium-channel blocking agents